← Leaderboards
David V. Serreze
Jackson Laboratory
$20,047,270
Attributed
$20,047,270
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,047,270 · 6
By mechanism
R01$16,418,447 · 3
UC4$2,500,000 · 1
U54$853,648 · 1
S10$275,175 · 1
Top collaborators
No co-investigators on record.
Most similar at Jackson Laboratory
Same institution · by research overlap
- Michele P Marron$606,628
- Yi-Guang Chen$9,291,015
- Caroline McPhee Leeth$893,180
- Anna Karolina Palucka$28,504,784
- Jeremy J Racine$1,630,055
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesAutoantigensInsulin-Dependent Diabetes MellitusCellsPancreasMediatingInsulinT-LymphocyteMouse ModelCd4 Positive T LymphocytesInbred Nod MiceResponsePlayLifeAutoimmune ResponsesGeneticFuturePredispositionAntigen-Presenting CellsReagentAttenuatedB-LymphocytesClinical TrialsAutoimmune Process
Grant awards (49)
B-lymphocyte Targeting Therapies for Autoimmune Diabetes$543,679
R01 · FY2025 · DK · contact PI
B-lymphocyte Targeting Therapies for Autoimmune Diabetes$521,931
R01 · FY2024 · DK · contact PI
B-lymphocyte Targeting Therapies for Autoimmune Diabetes$543,679
R01 · FY2023 · DK · contact PI
B-lymphocyte Targeting Therapies for Autoimmune Diabetes$531,699
R01 · FY2022 · DK · contact PI
B-lymphocyte Targeting Therapies for Autoimmune Diabetes$537,506
R01 · FY2021 · DK · contact PI
B-lymphocyte Targeting Therapies for Autoimmune Diabetes$539,746
R01 · FY2020 · DK · contact PI
B-lymphocyte Targeting Therapies for Autoimmune Diabetes$550,533
R01 · FY2019 · DK · contact PI
Project 2 - Type I Diabetes Project$172,944
U54 · FY2019 · OD · contact PI
Diabetogenic Role of MHC Class I Alleles in NOD Mice$558,600
R01 · FY2018 · DK · contact PI
B-lymphocyte Targeting Therapies for Autoimmune Diabetes$550,534
R01 · FY2018 · DK · contact PI
Project 2 - Type I Diabetes Project$173,301
U54 · FY2018 · OD · contact PI
B-lymphocyte Targeting Therapies for Autoimmune Diabetes$381,112
R01 · FY2017 · DK · contact PI
Diabetogenic Role of MHC Class I Alleles in NOD Mice$380,625
R01 · FY2017 · DK · contact PI
Project 2 - Type I Diabetes Project$164,575
U54 · FY2017 · OD · contact PI
Diabetogenic Role of MHC Class I Alleles in NOD Mice$111,057
R01 · FY2017 · DK · contact PI
B-lymphocyte Targeting Therapies for Autoimmune Diabetes$383,996
R01 · FY2016 · DK · contact PI
Diabetogenic Role of MHC Class I Alleles in NOD Mice$380,625
R01 · FY2016 · DK · contact PI
Project 2 - Type I Diabetes Project$173,316
U54 · FY2016 · OD · contact PI
B-lymphocyte Targeting Therapies for Autoimmune Diabetes$383,996
R01 · FY2015 · DK · contact PI
Diabetogenic Role of MHC Class I Alleles in NOD Mice$380,625
R01 · FY2015 · DK · contact PI
Project 2 - Type I Diabetes Project$169,512
U54 · FY2015 · OD · contact PI
B-lymphocyte Targeting Therapies for Autoimmune Diabetes$383,980
R01 · FY2014 · DK · contact PI
Diabetogenic Role of MHC Class I Alleles in NOD Mice$380,625
R01 · FY2014 · DK · contact PI
B-lymphocyte Targeting Therapies for Autoimmune Diabetes$383,929
R01 · FY2013 · DK · contact PI
Diabetogenic Role of MHC Class I Alleles in NOD Mice$358,803
R01 · FY2013 · DK · contact PI
Type 1 Diabetes Mouse Resource (T1DR)$2,500,000
UC4 · FY2012 · DK · contact PI
Diabetogenic Role of MHC Class I Alleles in NOD Mice$371,817
R01 · FY2012 · DK · contact PI
Diabetogenic Role of MHC Class I Alleles in NOD Mice$371,817
R01 · FY2011 · DK · contact PI
Diabetogenic Role of MHC Class I Alleles in NOD Mice$449,250
R01 · FY2010 · DK · contact PI
Diabetogenic Role of H-2g7 Class I Alleles in NOD Mice$369,040
R01 · FY2009 · DK · contact PI
Antigen Presenting Cell Defects in Autoimmune Diabetes$327,724
R01 · FY2009 · DK · contact PI
Diabetogenic Role of H-2g7 Class I Alleles in NOD Mice$369,040
R01 · FY2008 · DK · contact PI
Antigen Presenting Cell Defects in Autoimmune Diabetes$327,724
R01 · FY2008 · DK · contact PI
Becton Dickinson LSR-II Analytical Cytometer (BD-LSR-II)$275,175
S10 · FY2008 · RR · contact PI
Diabetogenic Role of H-2g7 Class I Alleles in NOD Mice$376,571
R01 · FY2007 · DK · contact PI
Antigen Presenting Cell Defects in Autoimmune Diabetes$334,412
R01 · FY2007 · DK · contact PI
Diabetogenic Role of H-2g7 Class I Alleles in NOD Mice$387,818
R01 · FY2006 · DK · contact PI
Antigen Presenting Cell Defects in Autoimmune Diabetes$344,400
R01 · FY2006 · DK · contact PI
Diabetogenic Role of H-2g7 Class I Alleles in NOD Mice$397,150
R01 · FY2005 · DK
ANTIGEN PRESENTING CELL DEFECTS IN AUTOIMMUNE DIABETES$330,000
R01 · FY2004 · DK
DIABETOGENIC ROLE OF H-2G7 CLASS I ALLELES IN NOD MICE$329,525
R01 · FY2004 · DK
ANTIGEN PRESENTING CELL DEFECTS IN AUTOIMMUNE DIABETES$330,000
R01 · FY2003 · DK
DIABETOGENIC ROLE OF H-2G7 CLASS I ALLELES IN NOD MICE$319,925
R01 · FY2003 · DK
ANTIGEN PRESENTING CELL DEFECTS IN AUTOIMMUNE DIABETES$330,000
R01 · FY2002 · DK
DIABETOGENIC ROLE OF H-2G7 CLASS I ALLELES IN NOD MICE$310,609
R01 · FY2002 · DK
ANTIGEN PRESENTING CELL DEFECTS IN AUTOIMMUNE DIABETES$330,000
R01 · FY2001 · DK
DIABETOGENIC ROLE OF H-2G7 CLASS I ALLELES IN NOD MICE$301,564
R01 · FY2001 · DK
ANTIGEN PRESENTING CELL DEFECTS IN AUTOIMMUNE DIABETES$330,000
R01 · FY2000 · DK
DIABETOGENIC ROLE OF H-2G7 CLASS I ALLELES IN NOD MICE$292,781
R01 · FY2000 · DK